MINNEAPOLIS--(BUSINESS WIRE)--May 25, 2006--MGI PHARMA, INC. (Nasdaq:MOGN - News), an oncology- and acute care-focused biopharmaceutical company, today announced that Gerard T. Kennealey, M.D. has joined the MGI PHARMA management team in the newly-created position of Senior Vice President, Clinical Development. During his 18-year tenure at AstraZeneca, Dr. Kennealey served in a variety of clinical, research and medical affairs leadership roles.
